{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:36:54Z","timestamp":1787697414378,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371305"],"award-info":[{"award-number":["32371305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32361133550"],"award-info":[{"award-number":["32361133550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071260"],"award-info":[{"award-number":["32071260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971186"],"award-info":[{"award-number":["31971186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-45-00032"],"award-info":[{"award-number":["24-45-00032"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["2023-ZDLSF-10"],"award-info":[{"award-number":["2023-ZDLSF-10"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.atherosclerosis.2025.120594","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:38:49Z","timestamp":1764175129000},"page":"120594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["C-reactive protein exacerbates high-fat diet-induced atherosclerosis via a liver-to-vessel axis that determines therapeutic efficacy of atorvastatin"],"prefix":"10.1016","volume":"412","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4124-8574","authenticated-orcid":false,"given":"Yu","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Melnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zufar A.","family":"Gabbasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-5590","authenticated-orcid":false,"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2092-3158","authenticated-orcid":false,"given":"En-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8595-3756","authenticated-orcid":false,"given":"Shang-Rong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.120594_bib1","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bjorkegren","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-Reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.2200831","article-title":"C-Reactive protein: the Most familiar stranger","volume":"210","author":"Ji","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.CIR.0000114526.50618.24","article-title":"C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"109","author":"Paul","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/CIRCULATIONAHA.105.556530","article-title":"Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice","volume":"112","author":"Schwedler","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib7","doi-asserted-by":"crossref","first-page":"13768","DOI":"10.1073\/pnas.0706027104","article-title":"Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia","volume":"104","author":"Kovacs","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib8","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3389\/fimmu.2020.01780","article-title":"Conformationally altered C-Reactive protein capable of binding to atherogenic lipoproteins reduces atherosclerosis","volume":"11","author":"Pathak","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib9","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1073\/pnas.0503202102","article-title":"Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice","volume":"102","author":"Hirschfield","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/01.ATV.0000171992.36710.1e","article-title":"No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E\u22173-leiden\/human C-reactive protein transgenic mice","volume":"25","author":"Trion","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib11","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1161\/01.ATV.0000171983.95612.90","article-title":"Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?","volume":"25","author":"Reifenberg","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib12","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1074\/jbc.M110.161414","article-title":"No reduction of atherosclerosis in C-reactive protein (Crp)-deficient mice","volume":"286","author":"Teupser","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib13","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/CIRCULATIONAHA.109.872796","article-title":"Human C-reactive protein does not promote atherosclerosis in transgenic rabbits","volume":"120","author":"Koike","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41574-023-00845-0","article-title":"Lipid droplet biogenesis and functions in health and disease","volume":"19","author":"Zadoorian","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.52601\/bpr.2024.240007","article-title":"Co-immunoprecipitation for identifying protein\u2013protein interaction on lipid droplets","volume":"10","author":"Fu","year":"2024","journal-title":"Biophysics Reports"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcmgh.2021.09.003","article-title":"C-Reactive protein protects against acetaminophen-induced liver injury by preventing complement overactivation","volume":"13","author":"Li","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1373\/clinchem.2008.108886","article-title":"The evolving role of C-reactive protein in atherothrombosis","volume":"55","author":"Devaraj","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/CIRCRESAHA.122.320263","article-title":"Animal models of atherosclerosis-supportive notes and tricks of the trade","volume":"130","author":"Gistera","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol-associated steatohepatitis in the development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib22","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","article-title":"Animal models for liver disease - a practical approach for translational research","volume":"73","author":"Nevzorova","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib24","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib25","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/1873-3468.14823","article-title":"CIDE proteins and their regulatory mechanisms in lipid droplet fusion and growth","volume":"598","author":"Xu","year":"2024","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib26","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-023-36775-8","article-title":"The rhythmic coupling of Egr-1 and Cidea regulates age-related metabolic dysfunction in the liver of male mice","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hep.25611","article-title":"Cidea promotes hepatic steatosis by sensing dietary fatty acids","volume":"56","author":"Zhou","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng1225","article-title":"Cidea-deficient mice have lean phenotype and are resistant to obesity","volume":"35","author":"Zhou","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib29","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1073\/pnas.0802063105","article-title":"CIDEA is associated with lipid droplets and insulin sensitivity in humans","volume":"105","author":"Puri","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fimmu.2019.00464","article-title":"The human FcgammaRII (CD32) family of Leukocyte FcR in health and disease","volume":"10","author":"Anania","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/cvr\/cvy181","article-title":"Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein","volume":"115","author":"Li","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/tra.12717","article-title":"CIDE family proteins control lipid homeostasis and the development of metabolic diseases","volume":"21","author":"Chen","year":"2020","journal-title":"Traffic"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm.2614","article-title":"Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids","volume":"18","author":"Wang","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.ATV.0000163840.63685.0c","article-title":"Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins","volume":"25","author":"Arnaud","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvae034","article-title":"Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials","author":"Xie","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib38","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120594_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025014923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025014923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:47:56Z","timestamp":1786016876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025014923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"alternative-id":["S0021915025014923"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120594","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-reactive protein exacerbates high-fat diet-induced atherosclerosis via a liver-to-vessel axis that determines therapeutic efficacy of atorvastatin","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120594"}}